An Overview of Therapeutic Management of Recurrent Pregnancy Loss
Journal: Open Access Journal of Gynecology (Vol.2, No. 3)Publication Date: 2017-07-29
Authors : Kulvinder Kochar Kaur Allahbadia GN; Singh M;
Page : 1-14
Keywords : RPL; Antiphospholipid syndrome; Low molecular weight heparin; IV Immunoglobulin; Intralipid therapy; Unexplained;
Abstract
Recurrent Pregnancy loss is defined as three or more consecutive pregnancy losses before 20 wks gestation. Usually causes are found in 70-80% of cases as chromosomal, anatomical defects, thrombophilias-both acquired and inherited, endocrine. But in 20-30% no definite cause is found. We searched electronic databases Pubmed from 1950-2016 using different keywords. As for the diagnosis, management remains controversial. Here we review the basis of use of various kinds of therapies like progesterone, low molecular weight heparin, aspirin, intravenous immunoglobulin, intra lipid therapy and steroids for routine use in RPL and is empiric use of these agents justified.
Other Latest Articles
- Carpo - Metacarpal Dorsal Dislocation of the Fourth and Fifth Fingers in a Skier (A Case Report)
- Incisional Hernia Repair among Reproductive Age Women
- Eliminating Andean Region Health Disparities via Human Papilloma Virus Vaccination Administration Programs Implementation
- Tranexamic Acid in Total Knee Replacement Reduces Wound Complication and Transfusion Rates; An Observational Study
- Case Report about Co - Axial Circuit Causing Hypercarbia
Last modified: 2018-05-24 21:54:55